Germany has one of the most advanced telemedicine systems in Europe, including a remote monitoring program for heart failure patients with advanced disease that uses both implantable and external devices. This approach clearly confirms that telemonitoring brings demonstrable clinical benefits. Seerlinq offers the world's first certified medical device that enables non-invasive home measurement of left ventricular filling pressure, a key indicator of heart failure. Thanks to artificial intelligence, the system detects deterioration promptly, reduces hospitalizations by more than 70%, and is already fully covered by insurance companies in Slovakia, while also entering the German market.